{
    "root": "519db8a9-48ab-4826-a2b3-6d67d6a24017",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "WYMZYA Fe",
    "value": "20250514",
    "ingredients": [],
    "indications": "WYMZYA\n                        TM\n                      Fe is indicated for use by females of reproductive potential to prevent pregnancy.",
    "contraindications": "Take one tablet by mouth at the same time every day. Tablets may be chewed or swallowed. ( 2.1 ) Take tablets in the order directed on the blister .( 2.1 )",
    "warningsAndPrecautions": "WYMZYA Fe [norethindrone and ethinyl estradiol tablets USP (chewable) and ferrous fumarate tablets] is available in a blister pack (NDC 68180-873-71) containing 28 tablets packed in a pouch (NDC 68180-873-71). Such three pouches are packaged in a carton (NDC 68180-873-73).\n                        Each blister contains 28 tablets in the following order:\n                        \n                           21 white to off-white, round (active), flat face, beveled edge      tablets debossed with \"LU\" on one side and \"M21\" on the other      side and each containing 0.4 mg norethindrone and 35 mcg ethinyl      estradiol.\n                           7 brown, mottled, round (non-hormonal placebo), flat face, beveled      edge tablets debossed with \"LU\" on one side and \"M22\" on the      other side and each containing 75 mg ferrous fumarate.",
    "adverseReactions": "WYMZYA Fe is contraindicated in females who are known to have or develop the following conditions:\n                  \n                     A high risk of      arterial or venous thrombotic diseases. Examples include women who are      known to:\n                           Smoke, if over      age 35 [see BOXED WARNING and WARNINGS AND PRECAUTIONS      (5.1)]\n                           \n                           Have deep vein      thrombosis or pulmonary embolism, now or in the past [see WARNINGS AND      PRECAUTIONS (5.1)]\n                           \n                           Have inherited      or acquired hypercoagulopathies [see WARNINGS AND PRECAUTIONS      (5.1)]\n                           \n                           Have      cerebrovascular disease [see WARNINGS AND PRECAUTIONS      (5.1)]\n                           \n                           Have coronary      artery disease [see WARNINGS AND PRECAUTIONS      (5.1)]\n                           \n                           Have      thrombogenic valvular or thrombogenic rhythm diseases of the heart (for      example, subacute bacterial endocarditis with valvular disease, or atrial      fibrillation) [see WARNINGS AND PRECAUTIONS (5.1)]\n                           \n                           Have      uncontrolled hypertension [see WARNINGS AND PRECAUTIONS      (5.4)]\n                           \n                           Have diabetes      mellitus with vascular disease [see WARNINGS AND PRECAUTIONS      (5.6)]\n                           \n                           Have headaches      with focal neurological symptoms or have migraine headaches with aura [see      WARNINGS AND PRECAUTIONS (5.7)]"
}